2023, Number 3
<< Back Next >>
Rev Hematol Mex 2023; 24 (3)
Nasal natural killer/T cell lymphoma
Rodríguez MG, Calderón QER, Luna SFF, Vásquez GN, Almeida NJS
Language: Spanish
References: 9
Page: 163-168
PDF size: 601.31 Kb.
ABSTRACT
Background: Natural killer (NK)/T-cell lymphoma is a rare, aggressive subtype of
non-Hodgkin lymphoma (NHL) that occurs predominantly in extranodal sites.
Clinical case: A 28-year-old female patient with nasal T/NK cell lymphoma. The
initial manifestations were epistaxis and nasal obstruction. A nasal tumor was found
and a biopsy was performed. The immunohistochemistry showed CD45 P63 t extranodal,
CD45 positive, ki67 40%. The bone marrow aspiration demonstrated evidence
of infiltration.
Conclusions: Extranodal T/NK cell lymphoma is an extremely rare oncological
condition, posing a diagnostic challenge. Therefore, in the presence of clinical suspicion
and paraclinical abnormalities, imaging studies for staging and prompt immunohistochemical
analysis should be obtained to accurately categorize patients and provide
appropriate treatment.
REFERENCES
Aozasa K, Takakuwa T, Hongyo T, Yang W. Nasal NK/T-celllymphoma: Epidemiology and pathogenesis. Int J Hematol 2008; 87: 110-7. doi: 10.1007/s12185-008-0021-7.
Valderrama E, Bracho G, Hernández A, Taylor LE, et al.Linfoma no Hodgkin de células grandes inmunofenotipoT/NK extraganglionar de tipo nasal (granuloma letal de lalínea media). A propósito de un caso. Dialnet 2013.
Liu J, He Z, Xie Y, Fang K, et al. Nasal natural killer/T celllymphoma with cutaneous involvement: Case report andChinese literature review reported in China mainland.J Dermatol 2003; 30: 735-741. doi: 10.1111/j.1346-8138.2003.tb00469.x.
Velázquez-Arenas OT, Vázquez-Martínez N, Méndez-OlveraO, Barboza-Quintana M, Gómez, Ocampo-Candiani J.Linfoma de células T/NK extranodal tipo nasal. ActasDermosifiliogr 2008; 99: 316-317. DOI: 10.1016/S0001-7310(08)74688-X.
Saavedra Ramírez JD. Linfoma nasal de células T/naturalkiller extranodal refractario mal diagnosticado, tratado demanera exitosa. Case Rep Oncol 2017; 10: 1092-1097. doi:10.1159/000484583.
Yamaguchi M, Suzuki S, Oguch M. Advances in thetreatment of extranodal NK/T-cell lymphoma, nasaltype. Blood 2018; 131: 2528-2540. doi: 10.1182/blood-2017-12-791418.
Pertiné B, Milone G, Ávila J, Muratore A, et al. Linfoma noHodgkin T/NK de nariz. Revista Hematología 2022; 26 (2):107-110. doi.org/10.48057/hematologa.v26i2.478.
De Jesús Vega-González MT, Avilés-Salas A, Pérez-MartínezR, Orozco-Anahuati AP. Linfoma extranodal de células T/NK tipo nasal. Presentación de un caso clínico. Revi CentroDermatológico Pascua 2017; 26 (2): 54-59.
Sosa MA, Costra C, Villafañe V, González Macchi ME. Linfomaextranodal de células NK/T tipo nasal. Rev HospitalPrivado de Comunidad 2022; 23 (1): 29-32.